|
ESTA
|
Establishment Labs Holdings Inc.
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
US
|
NASDAQ
|
|
ETON
|
Eton Pharmaceutcials, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
EVLV
|
Evolv Technologies, Inc
|
US
|
NASDAQ
|
|
EVOK
|
Evoke Pharma, Inc.
|
US
|
NASDAQ
|
|
EW
|
Edwards Lifesciences Corporation
|
US
|
NYSE
|
|
EXAS
|
Exact Sciences Corporation
|
US
|
NASDAQ
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FBIOP
|
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
US
|
NASDAQ
|
|
FBRX
|
Forte Biosciences, Inc.
|
US
|
NASDAQ
|
|
FIXX
|
Homology Medicines, Inc.
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
US
|
NASDAQ
|
|
FMS
|
Fresenius Medical Care AG
|
US
|
NYSE
|
|
FNCH
|
Finch Therapeutics Group, Inc.
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FONR
|
Fonar Corporation
|
US
|
NASDAQ
|
|
FULC
|
Fulcrum Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FWP
|
Forward Pharma A/S
|
US
|
NASDAQ
|